PTGX Competitors & Alternatives
Compare Protagonist Therapeutics Inc with similar stocks in the same industry
Biotechnology
PTGX
Main Stock$139.19
Tradestie Score
67
Market Cap
$3.98B
P/E Ratio
136.8
Revenue Growth
37.5%
Analyst Upside
+25.5%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.44
|
$10.53B | 162.2 | 59 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$44.00
|
$10.49B | - | 68 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$66.91
|
$10.22B | - | 73 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$499.71
|
$10.01B | - | 53 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.40
|
$9.33B | 62.5 | 57 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$114.03
|
$8.88B | 256.1 | 49 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$106.94
|
$8.77B | 32.4 | 52 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$205.89
|
$8.57B | - | 53 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$28.35
|
$8.53B | 3.2 | 40 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$233.01
|
$8.30B | 15.8 | 61 | Compare |
More PTGX Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry